A Study Evaluating Talazoparib (BMN 673) | 動物用藥查詢網
![A Study Evaluating Talazoparib (BMN 673)](https://i.imgur.com/TbfVXFL.jpg)
AStudyEvaluatingTalazoparib(BMN673),aPARPInhibitor,inAdvancedand/orMetastaticBreastCancerPatientsWithBRCAMutation(EMBRACAStudy)(EMBRACA) ...
![A Study Evaluating Talazoparib (BMN 673)](https://i.imgur.com/TbfVXFL.jpg)
OlympiAD trial Talazoparib Brocade 3 trial DESTINY trial EMBRACA trial PROfound trial OlympiAD olaparib Brocade 3 trial Nabpaclitaxel Nct02000622 Olaparib BRCA talazoparib仿單 talazoparib中文 talazoparib健保 talzenna仿單 VITRAKVI Talazoparib mce 達勝癌 Olaparib canaural耳藥 COUNTRY YEAR INDUSTRIAL CO., LTD 身可補電解質發泡錠 冠泰利康軟膠囊功效 四環黴素抗生素 達畜美101一般鴨用預拌劑副作用 紅黴素軟膏哪裡買 小三美日詐騙
A Study Evaluating Talazoparib (BMN 673) | 動物用藥查詢網
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) (EMBRACA) ... Read More
final overall survival results from the EMBRACA trial | 動物用藥查詢網
由 JK Litton 著作 · 2020 · 被引用 150 次 — EMBRACA is the largest PARP monotherapy trial to date in ABC. Talazoparib significantly prolonged progression-free survival (PFS) versus ... Read More
final overall survival results from the EMBRACA trial | 動物用藥查詢網
由 JK Litton 著作 · 2020 · 被引用 150 次 — Background: In EMBRACA, talazoparib prolonged progression-free survival versus chemotherapy (hazard ratio [HR] 0.542 [95% confidence interval ( ... Read More
Final Overall Survival Results From the Phase III EMBRACA ... | 動物用藥查詢網
2020年4月27日 — EMBRACA is the largest trial of PARP monotherapy to date in patients with germline BRCA-mutated, locally advanced or metastatic HER2-negative ... Read More
Talazoparib in Patients with Advanced Breast Cancer and a ... | 動物用藥查詢網
由 JK Litton 著作 · 2018 · 被引用 1383 次 — The EMBRACA trial was a controlled, phase 3 clinical trial involving patients with advanced breast cancer that expresses a germline BRCA1/2 ... Read More
Talazoparib versus chemotherapy in patients with germline ... | 動物用藥查詢網
由 JK Litton 著作 · 2020 · 被引用 150 次 — The phase III EMBRACA trial (NCT01945775) compared the efficacy and safety of talazoparib with physician's choice of chemotherapy in patients with HER2-negative ... Read More
相關資訊整理
![](https://i.imgur.com/TbfVXFL.jpg)
速滅淨 33% SULMEZINE 33% INJ.
速滅淨33%有哪些副作用?由公源藥品股份有限公司觀音廠製造的速滅淨33%是治療什麼的?藥品成分是什麼?以下為大家提供詳細的...
![](https://i.imgur.com/TbfVXFL.jpg)
高化維五○○ COFAVIT 500
高化維五○○有哪些副作用?由東盈實業股份有限公司製造的高化維五○○是治療什麼的?藥品成分是什麼?以下為大家提供詳細的「高...